These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 16178727)
1. Structure-activity relationships of p38 mitogen-activated protein kinase inhibitors. Bolós J Mini Rev Med Chem; 2005 Sep; 5(9):857-68. PubMed ID: 16178727 [TBL] [Abstract][Full Text] [Related]
2. Recent developments of p38α MAP kinase inhibitors as antiinflammatory agents based on the imidazole scaffolds. Kong TT; Zhang CM; Liu ZP Curr Med Chem; 2013; 20(15):1997-2016. PubMed ID: 23317165 [TBL] [Abstract][Full Text] [Related]
3. p38 MAP kinase inhibitors as anti inflammatory agents. Amir M; Somakala K; Ali S Mini Rev Med Chem; 2013 Dec; 13(14):2082-96. PubMed ID: 24107108 [TBL] [Abstract][Full Text] [Related]
4. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking. Ravindra GK; Achaiah G; Sastry GN Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839 [TBL] [Abstract][Full Text] [Related]
5. p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies. Gangwal RP; Bhadauriya A; Damre MV; Dhoke GV; Sangamwar AT Curr Top Med Chem; 2013; 13(9):1015-35. PubMed ID: 23651481 [TBL] [Abstract][Full Text] [Related]
6. Tri- and tetrasubstituted imidazoles as p38α mitogen-activated protein kinase inhibitors. Laufer S; Hauser D; Stegmiller T; Bracht C; Ruff K; Schattel V; Albrecht W; Koch P Bioorg Med Chem Lett; 2010 Nov; 20(22):6671-5. PubMed ID: 20934337 [TBL] [Abstract][Full Text] [Related]
7. Successful structure-based design of recent p38 MAP kinase inhibitors. Karcher SC; Laufer SA Curr Top Med Chem; 2009; 9(7):655-76. PubMed ID: 19689372 [TBL] [Abstract][Full Text] [Related]
8. Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors. Das J; Moquin RV; Pitt S; Zhang R; Shen DR; McIntyre KW; Gillooly K; Doweyko AM; Sack JS; Zhang H; Kiefer SE; Kish K; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K Bioorg Med Chem Lett; 2008 Apr; 18(8):2652-7. PubMed ID: 18359226 [TBL] [Abstract][Full Text] [Related]
9. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region. Laufer SA; Hauser DR; Domeyer DM; Kinkel K; Liedtke AJ J Med Chem; 2008 Jul; 51(14):4122-49. PubMed ID: 18578517 [TBL] [Abstract][Full Text] [Related]
11. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases. Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814 [TBL] [Abstract][Full Text] [Related]
12. New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Peifer C; Wagner G; Laufer S Curr Top Med Chem; 2006; 6(2):113-49. PubMed ID: 16454763 [TBL] [Abstract][Full Text] [Related]
13. Amide-based inhibitors of p38alpha MAP kinase. Part 1: discovery of novel N-pyridyl amide lead molecules. Luedtke GR; Schinzel K; Tan X; Tester RW; Nashashibi I; Xu YJ; Dugar S; Levy DE; Jung J Bioorg Med Chem Lett; 2010 Apr; 20(8):2556-9. PubMed ID: 20346653 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of bi-thiazole-2,2'-diamines as kinase inhibitory scaffolds. Ngoei KR; Ng DC; Gooley PR; Fairlie DP; Stoermer MJ; Bogoyevitch MA Biochim Biophys Acta; 2013 Jun; 1834(6):1077-88. PubMed ID: 23410953 [TBL] [Abstract][Full Text] [Related]
15. Insight into the structural determinants of imidazole scaffold-based derivatives as p38 MAP kinase inhibitors by computational explorations. Huang C; Li Y; Ren H; Wang J; Shao L; Zhang S; Li G; Yang L Curr Med Chem; 2012; 19(23):4024-37. PubMed ID: 22680637 [TBL] [Abstract][Full Text] [Related]
16. Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006-2008. Pettus LH; Wurz RP Curr Top Med Chem; 2008; 8(16):1452-67. PubMed ID: 18991731 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and characterization of N', N"-diaryl ureas as p38 kinase inhibitors. Kulkarni RG; Laufer S; Mangannavar C; Garlapati A Med Chem; 2013 Mar; 9(2):213-21. PubMed ID: 22946566 [TBL] [Abstract][Full Text] [Related]
18. P38 MAP kinase inhibitors: evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes. Natarajan SR; Doherty JB Curr Top Med Chem; 2005; 5(10):987-1003. PubMed ID: 16178742 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase. Kim DK; Lim JH; Lee JA; Dewang PM Bioorg Med Chem Lett; 2008 Jul; 18(14):4006-10. PubMed ID: 18571921 [TBL] [Abstract][Full Text] [Related]
20. Small molecular anti-cytokine agents. Wagner G; Laufer S Med Res Rev; 2006 Jan; 26(1):1-62. PubMed ID: 16283677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]